The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

To inquire about sponsorship opportunities, contact Laura Rudberg.

Our annual DEI Conference provides an opportunity for the life sciences community at all levels and positions to gather and learn about equity, diversity, and inclusion best practices from experts and colleagues, hear from those at life sciences companies who are successfully implementing DEI related initiatives, and gives attendees the opportunity to connect with industry peers seeking to solve the same challenges. This conference regularly brings together hundreds of people working formally or informally in DEI from every size company and covers topics ranging from recruitment to retention to advancement to executive culture and supplier diversity.

To inquire about sponsorship opportunities, contact Laura Rudberg.

One of MassBio’s most popular events of the year, the Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization, but throughout the drug development cycle. The program includes panel discussions, case study presentations (spotlighting industry/patient partnerships), and an inspirational keynote address.

To inquire about sponsorship opportunities, contact Laura Rudberg.

With policies impacting our industry at the forefront of state legislators’ minds, MassBio’s annual Policy Leadership Breakfast will debate the most pressing policy initiatives facing the life sciences industry. This event is a must-attend for senior industry leaders, policymakers and life sciences government affairs executives.

The event includes keynotes presentations and panel discussions designed to educate and promote an open dialogue. Speakers will address the necessary shift in mindset from measuring costs to measuring value, whether that’s exploring new models for more efficient R&D, piloting innovative pricing models, or working directly with patients to define desired outcomes and endpoints.

To express interest in sponsoring or exhibiting at this event, contact Susan Martin.

Every year, in conjunction with NORD and RareDiseaseDay.org, MassBio celebrates Rare Disease Day by bringing together over 450 industry stakeholders to elevate public understanding of rare diseases and call attention to the special challenges people with these ailments face.

To inquire about sponsorship opportunities, contact Laura Rudberg.

In 2019, we rebranded MassBio’s Annual Meeting as the State of Possible Conference to celebrate what’s now possible in the industry that wasn’t five or 10 years ago. This Premier Conference draws over 600 industry leaders from Massachusetts and beyond to debate the most timely and critical challenges facing the life sciences to ensure we can continue this incredible success.

Attendees will hear from the brightest minds in the industry through keynotes, panel discussions, ample networking opportunities, and our Possible Talks®, 15-minutes of inspiring and engaging content in the style of a TED Talk. The event will recognize and award those leaders who fight every day to improve the lives of patients and those around them.

“It’s the Woodstock of Life Sciences, with all star performers playing their greatest hits all on one stage.” – 2019 State of

Possible Conference attendee

To inquire about sponsorship opportunities, contact Laura Rudberg.

Clinical Development, Biostatistics & Data Management (BSDMCT) 

• John Goldberg, Senior Vice President, Clinical Development at Oncorus
• Jillian Farrel, Content & PR Manager, Halloran Consulting Group
• David Sherris, President & CEO, Penrose TX

Drug Discovery (DD) 

• Monica Gostissa, PhD, Head of Pharmacology, Jounce Therapeutics
• Shuying He, Senior Director, Eli Lilly
• William Marks, Strategy & Operations, Seismic Therapeutics
• Andy Snyder

Drug Formulation Development, Manufacturing & Supply   

• Lisa Wyman, Senior Vice President, Technical Operations, Acceleron Pharma

• Parika Petaipimol, Head of Technical Operations & Program Management, UpstreamBio

Business Development and Finance (BD/Fin)

• Charmaine Demanuele, Director of Biostatistics, Pfizer 

Medical Device, Diagnostics & Digital Health (MedDev, AI, ML) 

• Anna Welland, Senior Project Manager, Entasis
• Nova Diop, SVP, Bench International
• Marc Cote, Executive Coach, FocalPoint Coaching

Academic Industry Relations  

• Kat Holliday, Senior Associate Director, Technology Transactions, Harvard University
• Janet Loesberg, SVP Global Medical Affairs, Blueprint Medicines

Nonprofit (NP)

• Milka Kostic, PhD, Program Director, Chemical Biology, Dana-Farber Cancer Institute

Human Resources (HR)

• Stacy Perro, VP of People, Emulate, Inc.
• Heidi Friedman Ono, Pharma USA

Legal & Regulatory

• Anu Gaur, Graduate Faculty, Northeastern University; Senior-Level US & Global Regulatory Affairs Strategist Leader
• Daniel Shores, Partner, Rothwell Figg

Marketing, Communications & Commercialization (MarComm)

• Linda Ruckel, Director of Communications, Boeringer-Ingelheim
• Aparna Raghavan, Dicerna Pharmaceuticals

Safety, Environmental & Facility Operations (SEF)

• Lauren Laidlaw, VP, Sales & Marketing, Safety Partners, Inc.
• Stephen Parsons, Senior Manager, Supply Chain, Finch Therapeutics Inc.